HealthcareServices

Bartonellosis Market Forecast 2026: Where the Industry Is Headed

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the bartonellosis market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Bartonellosis Market reach by 2030 starting from 2026 levels?

The bartonellosis market has seen considerable expansion in recent years. It is anticipated to expand from $1.3 billion in 2025 to $1.46 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Historically, this growth can be ascribed to several factors, including an escalating incidence of cat scratch disease, enhanced diagnostic proficiencies for infectious diseases, the availability of antibiotic treatments, the proliferation of hospital diagnostic laboratories, and heightened clinician awareness concerning bartonella infections.

The bartonellosis market size is anticipated to experience substantial expansion over the upcoming years. By 2030, this market is projected to reach $2.24 billion, demonstrating a compound annual growth rate (CAGR) of 11.3%. This projected growth during the forecast period is primarily driven by factors such as the accelerated development of rapid diagnostic assays, an amplified emphasis on timely intervention for systemic infections, the broadening of specialized infectious disease care services, the increasing uptake of precise antibiotic treatment plans, and heightened investment in research concerning zoonotic diseases. Key trends anticipated within the forecast period encompass a greater embrace of molecular diagnostic methodologies, a surge in the application of PCR-based testing, heightened public consciousness regarding zoonotic infections, the broadening of specific antibiotic treatment protocols, and an intensified concentration on identifying diseases at early stages.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp

Which Drivers Are Influencing Long-Term Growth In The Bartonellosis Market?

The increasing occurrences of zoonotic diseases are projected to stimulate the growth of the bartonellosis market moving forward. Zoonotic diseases are defined as illnesses transmitted from animals to humans, either directly or via vectors. The escalation in zoonotic disease incidences is attributed to factors such as enhanced human-animal interactions, environmental alterations, deforestation, global travel, and the spread of pathogens between species. Bartonellosis serves as a prime example of zoonotic diseases, demonstrating how bacterial pathogens, conveyed through animal vectors like fleas, ticks, and lice, can infect humans, leading to diverse clinical symptoms and underscoring the vital importance of understanding vector-borne disease transmission in public health. For instance, in December 2024, the European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC), a Europe-based public health authority, reported human campylobacteriosis cases rose to 148,181, reflecting a 4.3% year-over-year increase from 139,225 cases in 2022. Similarly, salmonellosis cases climbed to 77,486, marking a 16.9% growth compared to 65,478 cases in 2022. Thus, the rise in incidences of zoonotic diseases is propelling the expansion of the bartonellosis market.

Which Segments Are Driving Activity In The Bartonellosis Market?

The bartonellosis market covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing

3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications

2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis

Which Trends Are Expected To Influence The Bartonellosis Market In The Upcoming Years?

Leading companies active in the Bartonellosis market are increasingly concentrating on technological advancements, such as multi-microbial phage modulation, to achieve a competitive edge. This multi-microbial phage modulation involves utilizing customized phage cocktails designed to target multiple intracellular pathogens concurrently, addressing the co-infections that frequently complicate Bartonella treatment. For instance, in November 2024, Biologix Center, a US-based biotechnology company, introduced Induced Native Phage Cocktails intended for patients with Bartonella and Babesia co-infections. This therapy incorporates pathogen-specific phage activation, daily adaptive dosing customized to patient microbial profiles, and improved penetration into persistent infection reservoirs. This innovation facilitates a comprehensive approach to complex co-infections, diminishes dependency on conventional antibiotics, and supports precision medicine strategies. By leveraging multi-microbial phage therapy, companies are progressing personalized treatment solutions within the Bartonellosis market, while also navigating the clinical validation and regulatory pathways characteristic of emerging biologic therapies.

Which Key Players Are Driving Competition In The Bartonellosis Market?

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

Which Region Is Projected To Lead The Bartonellosis Market During The Forecast Period?

North America was the largest region in the bartonellosis market in 2025. The regions covered in the bartonellosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Bartonellosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21111&type=smp

Browse Through More Reports Similar to the Global Bartonellosis Market 2026, By The Business Research Company

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Anti Infective Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795